The pharmaceutical industry’s growth prospects appear promising due to advances in the manufacturing of personalized medicines, expanding healthcare needs, a robust drug pipeline, growing investments in research and development, and favorable government policies.
Given the industry’s solid growth prospects, investors could consider buying fundamentally strong pharma stocks Viatris Inc. (VTRS), Wave Life Sciences Ltd. (WVE), and MEI Pharma, Inc. (MEIP).
